Skip to main content

School of Pharmaceutical Sciences, Universiti Sains Malaysia

  • Qualification

    PhD (Clin.Pharmacy), M.Phil, Pharm-D

  • Senior Lecturer

    Discipline of Clinical Pharmacy

  • Room

    J01 Room 108

  • Contact

    +604-6577888 Ext. 2251

  • Email

    aliqureshi@usm.my

Author ID

Ali Qureshi, Dr

Over 10 years of lectureship experience in the field of Pharmacy. Particularly experienced in teaching Clinical Pharmacy, Geriatric Pharmacy, Evidence Based Medicine, Pharmacovigilance, Pharmacotherapy, and Advanced therapeutics in Infectious diseases. Research experience in COVID-19 related prediction-based models, survival analysis/time to event, post-COVID sequelae.

Research interest:

  • Clinical Pharmacy,
  • Pharmacoepidemiology,
  • Digital Health / Telepharmacy
  • Pharmacovigilance
  • Time-to-Event modelling
  • Prediction-based and forecasting models
  • KAP Studies
  • Interventional Studies (RCT)

  1. Time-to-Event Modelling
  2. Prediction-Based Models
  3. Risk Analysis
  4. Sensitivity Analysis (ROC)
  1. Qureshi A, et al. (August 18, 2024) Impact of Long-Term Non- Communicable Diseases on SARS-COV2 Hospitalized PatientsSupported by Radiological Imaging in Southern Pakistan. Cureus 16(8): e67110. doi:10.7759/cureus.67110.
  2. QURESHI A., SYED SULAIMAN S.A., KUMAR N., YASIN M.U., & DAUD N.A.A.B, Risk Factors for Post Acute Sequelae of COVID- 19 among Recovered Patients in Southern Pakistan: a Prospective Multicentred Study, Lat. Am. J. Pharm.43(8): (2024).
  3. Qureshi A, et al (2023) Prevalence of post-vaccine side effects among COVID-19 immunized community of Southern Pakistan. PLoS ONE 18(5): e0285736.
  4. Qureshi A, Syed Sulaiman SA, Kumar N, Qureshi PAAA. Knowledge, perception, and fear among the global population towards newly evoked variant Omicron (B.1.1.529). PLoS One. 2022 Jul 6;17(7):e0270761.
  5. Kumar N, Sulaiman SAS, Hashmi FK, Qureshi A, Survey data of public in Sindh Pakistan regarding willingness to accept COVID-19 vaccination. PLoS One. 2022 Aug 25;17(8):e0270900. doi:
    10.1371/journal.pone.0270900. PMID: 36006986; PMCID: PMC9409498.
  6. Qureshi, A., Sulaiman, S. A. B. S., et al(2021) “Obesity as a Predominant Factor in Covid-19 Mortality; Relationship between Increased BMI and Mortality in Covid-19”, Journal of Pharmaceutical Research International, 33(27B), pp. 8- 15. doi:10.9734/jpri/2021/v33i27B31497.
  1. FAR355
  2. FAR468
  1. Malaysian Journal of Pharmaceutical Sciences (Reviewer)
  2. Journal of Research in Pharmacy (Reviewer)
  3. Asian Journal of Medicine and Health (Reviewer)
  4. Journal of Pharmaceutical Research International (Reviewer)
  5. Cureus Journal of Medical Sciences (Reviewer)